Literature DB >> 4000064

Enzymatic profile of clinical isolates of Acinetobacter calcoaceticus.

C L Poh, G K Loh.   

Abstract

The enzymatic profiles of 109 clinical isolates of Acinetobacter calcoaceticus subsp. anitratus and lwoffi were determined with conventional plate tests and the rapid API ZYM system (Analytab Products, Plainview, N.Y.). The majority of strains tested lacked DNase, hemolysin, protease, elastase and gelatinase. Strong enzymatic activities of butyrate esterase (C4), caprylate esterase (C8) and leucine arylamidase were detected in all isolates. No trypsin, chymotrypsin, alkaline phosphatase or glucosidase activities were present. This profile was characteristic of all isolates examined by the API ZYM system and could serve as a useful diagnostic feature of Acinetobacter calcoaceticus subsp. anitratus and subsp. lwoffi.

Entities:  

Mesh:

Year:  1985        PMID: 4000064     DOI: 10.1007/bf02123668

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  12 in total

1.  Fulminating and fatal pneumonia and septicaemia due to achromobacter antitratus.

Authors:  D L GARDNER; A PINES; S M STEWART
Journal:  Br Med J       Date:  1960-04-09

2.  Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern.

Authors:  H F Retailliau; A W Hightower; R E Dixon; J R Allen
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

3.  Mimeae meningitis and sepsis.

Authors:  W D Donald; W M Doak
Journal:  JAMA       Date:  1967-04-24       Impact factor: 56.272

4.  Acinetobacter calcoaceticus-an opportunistic pathogen.

Authors:  R B Pal; V V Kale
Journal:  J Postgrad Med       Date:  1981-10       Impact factor: 1.476

5.  Bacteriuria caused by Acinetobacter calcoaceticus biovars in a normal population and in general practice.

Authors:  S Hoffmann; C E Mabeck; R Vejlsgaard
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

6.  In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.

Authors:  I Garcia; V Fainstein; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

7.  Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.

Authors:  D E Ohman; S J Cryz; B H Iglewski
Journal:  J Bacteriol       Date:  1980-06       Impact factor: 3.490

8.  Acinetobacter anitratus infections in man.

Authors:  M L Thong
Journal:  Aust N Z J Med       Date:  1975-10

9.  A cluster of Acinetobacter Pneumonia in foundry workers.

Authors:  L G Cordes; E W Brink; P J Checko; A Lentnek; R W Lyons; P S Hayes; T C Wu; D G Tharr; D W Fraser
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

10.  Enzymatic profile of Pseudomonas paucimobilis.

Authors:  D L Smalley
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

View more
  1 in total

Review 1.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.